Hormone devices are the most commonly used means of reversible contraception in the United States and most developed countries. Since the introduction of the original oral contraceptives in 1960, the most common estrogen and progestin oral contraceptives have been reduced in doses of estrogen by about 2/3, with serious side effects being far less common. Side effects may occur and this article will discuss common side effects and their management.
This article is not comprehensive or addresses the rarer risk of more serious hormonal contraception, such as deep vein thrombosis, stroke and breast cancer.
- Acne is more common in hormonal contraceptives such as depo-provera and mini-pills, and is less common in some newer low-dose combination oral contraceptives.
- Mirina IUD, depoprovera and continuous use of OCP or continuous use of Nuvaring, amenorrhea are more common and expected.
- For continuous use of OCP, mini pills and Implanon, breakthrough bleeding is more common. For the lowest dose of estrogen combination OCP, it is less common but still quite common.
- Weight gain: May be associated with depo-provera, not showing other types of hormone violations.
- Reduced libido: only very low doses of estrogen OCPs [15 micrograms estrogen per day]
- Increased vaginal discharge: same as Nuvaring, not external type.
- Headache: All hormonal contraceptives are visible and are more common in women over the age of 35.
- Oily skin: Commonly only progestogen-like depo-provera and mini-pill, may be associated with Implanon.
Most women who do not have a major contraindication to hormonal contraceptives can find a type of device that meets their needs and provides an effective and well tolerated device. AFP provides a more comprehensive review
Orignal From: Common side effects of hormone receptors
No comments:
Post a Comment